Ingalls & Snyder LLC
- SEC CIK
- 0001041885
- Latest filing
- Aug 14, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,415
- Value
- $5.00K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,415 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 11,415 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 11,415 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 11,415 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 11,415 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 11,415 | $25.0K | <0.1% | −2,000−14.9% | Reduced | Holders |
| Q4 2024 | 13,415 | $21.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 13,415 | $27.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 13,415 | $47.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 13,415 | $37.0K | <0.1% | +2,000+17.5% | Added | Holders |
| Q4 2023 | 11,415 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 11,415 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 11,415 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 11,415 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 11,415 | $29.0K | <0.1% | −2,700−19.1% | Reduced | Holders |
| Q3 2022 | 14,115 | $60.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 14,115 | $39.0K | <0.1% | +14,115 | New | Holders |